Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Interest Expense

Cost of servicing the company's debt during the period.

Nakamoto Inc.NASDAQ: NAKA

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense growth accelerates

Q1 FY2026 interest expense of $4.22M rose 70233.3% year over year, ahead of the +3194.6% change in trailing-twelve-month interest expense. Sequentially, it fell 40.1% from the prior quarter.

Context

  • Interest expense amounted to 387.7% of revenue in FY2025, up 373.2 pp from a year earlier.
  • Interest expense increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +70233.3% holds above the trailing-twelve-month pace of +3194.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.22M-40.1% QoQ
Last fiscal yearDec 2025
$7.06M+1694.5% YoY
LTMMar 2026
$11.27M+3194.6% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+70233.3%——
1 year+1694.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
7.06M USD
Year-over-year change
+1694.5%

Interest Expense vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 interest expense of $11.27M is the 2nd highest of the 11 companies compared; the peer median is $328.08K.
  • Its year-over-year change of +3194.6% is the highest of 8, against a peer median of -14.6%.
  • Interest expense amounts to 287.6% of revenue for NAKA, versus a peer median of 0.0%.
NAKA Competitors Peer median
Interest Expense for NAKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHDefinitive Healthcare Corp.LTM Mar 2026$11.48M -14.6%+0.3%4.8%
NAKANakamoto Inc.LTM Mar 2026$11.27M +3194.6%—287.6%
CLLSCellectis S.A.LTM Mar 2026$8.49M +11.7%+28.9%12.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$5.56M +379.5%+92.4%6.9%
AGLAgilon Health, Inc.LTM Mar 2026$3.32M -48.3%+14.0%0.1%
DBVTDBV Technologies S.A.LTM Mar 2026$656.17K +480.7%——
DCTHDelcath Systems, Inc.LTM Mar 2026$0 -100.0%—0.0%
SLPSimulations Plus, Inc.LTM Feb 2026$0 ——0.0%
LYELLyell Immunopharma, Inc.LTM Mar 2026$0 ——0.0%
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$0 ———
AMRNAmarin Corporation plcLTM Mar 2026$0 -100.0%-22.4%0.0%
Peer median (excluding NAKA) $328.08K-14.6%+14.0%0.0%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.5M3.79M3.77M2.72M1.82M
Cost of Revenue1.59M152.39K226.17K3.56M11.09M
Gross Profit914.92K3.63M3.54M(842.57K)(9.27M)
Gross Margin36.5%96.0%94.0%-31.0%-508.8%
Research & Development002.5K377.73K0
Selling, General & Admin853.58K6.27M5.05M1.91M11.76M
Operating Expenses853.58K6.33M5.16M2.5M187.87M
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
EBITDA124.74K(2.42M)(1.36M)(3M)(44.93M)
EBITDA Margin5.0%-63.9%-36.0%-110.4%-2466.7%
Operating Income61.34K(2.69M)(1.62M)(3.35M)(197.14M)
Operating Margin2.4%-71.1%-43.0%-123.1%-10824.0%
Interest Income00000
Interest Expense0055.84K393.45K7.06M
Other Income / Expenses88K152.82K2.76K(270.88K)144.91M
Income Before Tax149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Pre-Tax Margin6.0%-67.1%-42.9%-133.0%-2867.6%
Income Tax Expense00000
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Net Margin6.0%-67.1%-42.9%-133.0%-2867.6%
EPS (Basic)0.03(0.43)(0.27)(0.67)(10.40)
EPS (Diluted)0.03(0.43)(0.27)(0.67)(10.40)
Weighted Avg Shares5.97M5.89M5.89M5.39M11.36M
Weighted Avg Shares (Diluted)5.97M5.89M5.89M5.39M11.36M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.